We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Buy 5 Growth Stocks to Enhance Your Portfolio Returns in November
Read MoreHide Full Article
Key Takeaways
PWR and BTSG benefit from infrastructure demand and expanding healthcare services.
PSX and VLO leverage refining strength, midstream expansion and debt reduction to support shareholder returns.
DINO benefits from favorable refining fundamentals, renewable fuels and initiatives to improve margins.
September and October are historically known as the worst-performing months for U.S. equities. This year, these two months ended on a mixed note. However, severe volatility affected U.S. stock markets in November after the U.S. mid-term election results.
However, Wall Street is likely to stabilize from here supported by reductions in U.S. government bond yields and crude oil prices. The Fed, too, may not be as aggressive with respect to interest rate hikes as expected.
At this stage, we have identified five growth stocks that investors should purchase to strengthen their portfolios in November. Growth investors are primarily focused on stocks with aggressive earnings or revenue growth, which should propel prices higher in the future.
The chart below shows the price performance of our five picks in the past three months.
Image Source: Zacks Investment Research
Quanta Services Inc.
Quanta Services is well-positioned to capitalize on robust infrastructure spending across utility, power generation, technology and load center markets. The ongoing expansion of artificial intelligence (AI) data centers, grid modernization, renewable energy generation and advanced manufacturing is driving customers to undertake larger, multiyear infrastructure programs.
Surging AI-related power demand and expanding utility investments are driving data center project opportunities, making data centers a central pillar of PWR’s long-term growth strategy. The company is heavily investing in deepening its vertical supply chain to offset the ongoing global uncertainties and rising inflation.
PWR is well-positioned to capitalize on robust infrastructure spending across utility, power generation, technology and load center markets. Management believes that the company is still in the early stages of the current demand cycle, with larger utility-generation and technology/load center programs expected to be built over the coming years.
Quanta Services has an expected revenue and earnings growth rate of 43.4% and 62.7%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 4.7% over the last 30 days.
BrightSpring Health Services Inc.
BrightSpring Health’s integrated pharmacy and provider platform benefits from the shift of complex care toward lower-cost home and community settings. Specialty and Infusion growth is supported by broader access to limited-distribution therapies, new launches and manufacturer partnerships.
BTSG’s rising home-health volumes, acquired branches and preferred payor relationships extend Provider Services reach. Coordinated care and high quality ratings support referrals and patient retention.
Greater scale, process standardization and automation are translating BTSG’s growth into higher margins. Improved cash generation and liquidity provide flexibility to fund new locations, infusion capacity and integration. BTSG’s raised 2026 outlook and expectation of sustained organic adjusted EBITDA growth in 2027 reinforce its long-term growth prospects.
BrightSpring Health has an expected revenue and earnings growth rate of 23.5% and 91%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 3.2% over the last seven days.
Phillips 66
Phillips 66’s integrated refining, midstream, chemicals, marketing and renewable fuels platform provides cash-flow diversity and commercial flexibility. High refinery utilization, wider margins and disciplined costs support earnings recovery. Midstream expansion and chemical projects broaden PSX’s future earnings capacity.
Portfolio reshaping strengthens PSX’s network, while rapid debt reduction and cash generation support dividends and repurchases. Refining profits underline the value of operational execution, though they remain exposed to volatile fuel spreads. PSX’s integrated asset base, infrastructure pipeline and flexible balance sheet support shareholder returns across changing markets.
Phillips 66 has an expected revenue and earnings growth rate of 23.9% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 5.5% over the last seven days.
Valero Energy Corp.
Valero Energy’s strong performance reflects its refining scale, feedstock flexibility, export access and shareholder returns. Limited spare refining capacity and low fuel inventories support product margins across VLO’s refineries.
Complex Gulf Coast assets can process discounted heavy crude and reach export markets. VLO’s St. Charles optimization project should raise output of higher-value products and improve the asset mix. Renewable diesel and ethanol provide earnings diversity, supported by fuel credit economics and production incentives.
Valero Energy has an expected revenue and earnings growth rate of 29.6% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 1.1% over the last seven days.
HF Sinclair Corp.
HF Sinclair has been benefiting from favorable refining fundamentals, a flexible regional asset base and projects that can improve margin capture through the cycle. Tight product supply and low inventories are supporting gasoline and distillate economics, while the El Dorado vacuum furnace and Go-West initiatives should expand DINO’s feedstock and logistics flexibility.
Renewables provide another earnings stream for DINO as higher credit values, tax benefits and volumes support profitability. The planned Lubricants & Specialties separation could sharpen DINO’s strategic focus and lower capital intensity, while retirement of the Mississauga refining assets may reduce exposure to volatile base oil cracks.
HF Sinclair has an expected revenue and earnings growth rate of 34.5% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 9.7% over the last seven days.
View the Zacks #1 Rank List
Image: Bigstock
Buy 5 Growth Stocks to Enhance Your Portfolio Returns in November
Key Takeaways
September and October are historically known as the worst-performing months for U.S. equities. This year, these two months ended on a mixed note. However, severe volatility affected U.S. stock markets in November after the U.S. mid-term election results.
However, Wall Street is likely to stabilize from here supported by reductions in U.S. government bond yields and crude oil prices. The Fed, too, may not be as aggressive with respect to interest rate hikes as expected.
At this stage, we have identified five growth stocks that investors should purchase to strengthen their portfolios in November. Growth investors are primarily focused on stocks with aggressive earnings or revenue growth, which should propel prices higher in the future.
The stocks are: Quanta Services Inc. (PWR - Free Report) , BrightSpring Health Services Inc. (BTSG - Free Report) , Phillips 66 (PSX - Free Report) , Valero Energy Corp. (VLO - Free Report) and HF Sinclair Corp. (DINO - Free Report) . Each of our picks sports a Zacks Rank #1 (Strong Buy) and has a Growth Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.
The chart below shows the price performance of our five picks in the past three months.
Image Source: Zacks Investment Research
Quanta Services Inc.
Quanta Services is well-positioned to capitalize on robust infrastructure spending across utility, power generation, technology and load center markets. The ongoing expansion of artificial intelligence (AI) data centers, grid modernization, renewable energy generation and advanced manufacturing is driving customers to undertake larger, multiyear infrastructure programs.
Surging AI-related power demand and expanding utility investments are driving data center project opportunities, making data centers a central pillar of PWR’s long-term growth strategy. The company is heavily investing in deepening its vertical supply chain to offset the ongoing global uncertainties and rising inflation.
PWR is well-positioned to capitalize on robust infrastructure spending across utility, power generation, technology and load center markets. Management believes that the company is still in the early stages of the current demand cycle, with larger utility-generation and technology/load center programs expected to be built over the coming years.
Quanta Services has an expected revenue and earnings growth rate of 43.4% and 62.7%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 4.7% over the last 30 days.
BrightSpring Health Services Inc.
BrightSpring Health’s integrated pharmacy and provider platform benefits from the shift of complex care toward lower-cost home and community settings. Specialty and Infusion growth is supported by broader access to limited-distribution therapies, new launches and manufacturer partnerships.
BTSG’s rising home-health volumes, acquired branches and preferred payor relationships extend Provider Services reach. Coordinated care and high quality ratings support referrals and patient retention.
Greater scale, process standardization and automation are translating BTSG’s growth into higher margins. Improved cash generation and liquidity provide flexibility to fund new locations, infusion capacity and integration. BTSG’s raised 2026 outlook and expectation of sustained organic adjusted EBITDA growth in 2027 reinforce its long-term growth prospects.
BrightSpring Health has an expected revenue and earnings growth rate of 23.5% and 91%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 3.2% over the last seven days.
Phillips 66
Phillips 66’s integrated refining, midstream, chemicals, marketing and renewable fuels platform provides cash-flow diversity and commercial flexibility. High refinery utilization, wider margins and disciplined costs support earnings recovery. Midstream expansion and chemical projects broaden PSX’s future earnings capacity.
Portfolio reshaping strengthens PSX’s network, while rapid debt reduction and cash generation support dividends and repurchases. Refining profits underline the value of operational execution, though they remain exposed to volatile fuel spreads. PSX’s integrated asset base, infrastructure pipeline and flexible balance sheet support shareholder returns across changing markets.
Phillips 66 has an expected revenue and earnings growth rate of 23.9% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 5.5% over the last seven days.
Valero Energy Corp.
Valero Energy’s strong performance reflects its refining scale, feedstock flexibility, export access and shareholder returns. Limited spare refining capacity and low fuel inventories support product margins across VLO’s refineries.
Complex Gulf Coast assets can process discounted heavy crude and reach export markets. VLO’s St. Charles optimization project should raise output of higher-value products and improve the asset mix. Renewable diesel and ethanol provide earnings diversity, supported by fuel credit economics and production incentives.
Valero Energy has an expected revenue and earnings growth rate of 29.6% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 1.1% over the last seven days.
HF Sinclair Corp.
HF Sinclair has been benefiting from favorable refining fundamentals, a flexible regional asset base and projects that can improve margin capture through the cycle. Tight product supply and low inventories are supporting gasoline and distillate economics, while the El Dorado vacuum furnace and Go-West initiatives should expand DINO’s feedstock and logistics flexibility.
Renewables provide another earnings stream for DINO as higher credit values, tax benefits and volumes support profitability. The planned Lubricants & Specialties separation could sharpen DINO’s strategic focus and lower capital intensity, while retirement of the Mississauga refining assets may reduce exposure to volatile base oil cracks.
HF Sinclair has an expected revenue and earnings growth rate of 34.5% and more than 100%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 9.7% over the last seven days.